4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF
The present invention is directed to 4'-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression o...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
18.05.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention is directed to 4'-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC. The present invention also provides processes for the preparation of 4'-substituted nucleoside derivatives of Formula (I) and derivatives thereof.
La présente invention concerne des dérivés nucléosidiques substitués en position 4' de formule I et leur utilisation dans l'inhibition de la transcriptase inverse du VIH, la prophylaxie d'une infection par le VIH, le traitement d'une infection par le VIH, et la prophylaxie, le traitement et le retardement de l'apparition ou de la progression du SIDA et/ou du complexe associé au SIDA. La présente invention concerne également des procédés pour la préparation de dérivés nucléosidiques substitués en position 4' de formule I et des dérivés de ceux-ci. |
---|---|
AbstractList | The present invention is directed to 4'-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC. The present invention also provides processes for the preparation of 4'-substituted nucleoside derivatives of Formula (I) and derivatives thereof.
La présente invention concerne des dérivés nucléosidiques substitués en position 4' de formule I et leur utilisation dans l'inhibition de la transcriptase inverse du VIH, la prophylaxie d'une infection par le VIH, le traitement d'une infection par le VIH, et la prophylaxie, le traitement et le retardement de l'apparition ou de la progression du SIDA et/ou du complexe associé au SIDA. La présente invention concerne également des procédés pour la préparation de dérivés nucléosidiques substitués en position 4' de formule I et des dérivés de ceux-ci. |
Author | GIBSON, ANDREW WILLIAM MCLAUGHLIN, MARK KONG, JONGROCK LIEBERMAN, DAVID R MILCZEK, ERIKA M BELYK, KEVIN M DIEGUEZ VAZQUEZ, ALEJANDRO PENG, FENG GIRIJAVALLABHAN, VINAY M CLEATOR, EDWARD KEEN, STEPHEN PHILIP WILLIAMS, MICHAEL J MOORE, JEFFREY C SONG, ZHIGUO JAKE |
Author_xml | – fullname: CLEATOR, EDWARD – fullname: DIEGUEZ VAZQUEZ, ALEJANDRO – fullname: SONG, ZHIGUO JAKE – fullname: KONG, JONGROCK – fullname: KEEN, STEPHEN PHILIP – fullname: MOORE, JEFFREY C – fullname: GIBSON, ANDREW WILLIAM – fullname: LIEBERMAN, DAVID R – fullname: WILLIAMS, MICHAEL J – fullname: MCLAUGHLIN, MARK – fullname: PENG, FENG – fullname: GIRIJAVALLABHAN, VINAY M – fullname: MILCZEK, ERIKA M – fullname: BELYK, KEVIN M |
BookMark | eNqFyj0LwjAQgOEMOvj1G8zm1EVLsWOaXOmBJOXu4lqKxEnSQv3_6ODu9PLAu1WrPOW0UVyeCo4NC0oUcNpHe4PA6EAT3IEYtJDxbAl7MV-h77BBCcTaeKd7gt6QEQyetXRAENq9Wj_H15IOv-7UsQWxXZHmaUjLPD5STu_BmnNdX6uyspf_xwexYTFb |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | INHIBITEURS NUCLEOSIDIQUES DE LA TRANSCRIPTASE INVERSE SUBSTITUES EN POSITION 4' ET PREPARATIONS ASSOCIEES |
ExternalDocumentID | CA2998646C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2998646C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:25:29 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2998646C3 |
Notes | Application Number: CA20162998646 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210518&DB=EPODOC&CC=CA&NR=2998646C |
ParticipantIDs | epo_espacenet_CA2998646C |
PublicationCentury | 2000 |
PublicationDate | 20210518 |
PublicationDateYYYYMMDD | 2021-05-18 |
PublicationDate_xml | – month: 05 year: 2021 text: 20210518 day: 18 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | MERCK SHARP & DOHME LIMITED MERCK SHARP & DOHME CORP |
RelatedCompanies_xml | – name: MERCK SHARP & DOHME LIMITED – name: MERCK SHARP & DOHME CORP |
Score | 3.3301353 |
Snippet | The present invention is directed to 4'-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
Title | 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210518&DB=EPODOC&locale=&CC=CA&NR=2998646C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT4MwFH-Z06g3nZr53YOZJyJj0I0DMVBKwDggtCy7GT5q9MIWh_Hft-CmXnbrR_LS_pLfe319fa8Ad0I0wcwCK8VQKxRdjDTFHJuaIrIxFlpuFKXRJDhPQ-yn-tPcmHfgbZML09YJ_WqLI0pGFZLvdauvl3-XWG77tnL1kL_LocWjxy13sPaOpf9iSDq7jkXjyI3IgBCL2IMwsaTWnWAdkx3YlYfoccMFOnOanJTlf4PiHcFeLGVV9TF0RNWDA7L5d60H-9N1uFs218xbnQDT7xWWOowHPJXKBoUpeaYRC1yKEjqjCaOIJ3bISBLE3Ja9IPQDJ-BRwpAdukgiHds_F1IMcZ8mNPJO4dajnPiKXN3LLxAvxN5sY3QG3WpRiT6g0jSzTMVZhsVQL001V4tXo9QnJS5NYajqOfS3SbnYPnUJhw2cTZx8OLmCbv3xKa6l-a3zmxa5b2SFhCU |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7Uaqw3rZr6LAdTT0RKYVsOxMCyBLQFwi6Nt4bHGr3QxmL8-y7Yqpfe9pFMdr_km9nZ2ZkFuOO8DmbmSM6Hai5rfKTKxthQZZ6OEVczPS_0OsF5FiAv0Z5e9JcWvG1zYZo6oV9NcUTBqFzwvWr09ervEstp3lauH7J3MbR8dJnpDDbesfBfdEFnxzZJFDohHmBsYmsQxKbQuhOkIbwH--KAPa65QOZ2nZOy-m9Q3GM4iISssjqBFi-70MHbf9e6cDjbhLtFc8O89SlQ7V6miU2ZzxKhbKQgwVMSUt8hUkzmJKZEYrEVUBz7EbNEzw883_ZZGFPJChxJIB1ZPxdSVGIeiUnonkHfJQx7sljd4heIBba22xidQ7tclrwHUmEYaaqgNEV8qBWGkin5q15okwIVBtcV5QJ6u6Rc7p7qQ8djs-li6gfPV3BUQ1vHzIeTa2hXH5_8RpjiKrttUPwGww-HGA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=4%27-SUBSTITUTED+NUCLEOSIDE+REVERSE+TRANSCRIPTASE+INHIBITORS+AND+PREPARATIONS+THEREOF&rft.inventor=CLEATOR%2C+EDWARD&rft.inventor=DIEGUEZ+VAZQUEZ%2C+ALEJANDRO&rft.inventor=SONG%2C+ZHIGUO+JAKE&rft.inventor=KONG%2C+JONGROCK&rft.inventor=KEEN%2C+STEPHEN+PHILIP&rft.inventor=MOORE%2C+JEFFREY+C&rft.inventor=GIBSON%2C+ANDREW+WILLIAM&rft.inventor=LIEBERMAN%2C+DAVID+R&rft.inventor=WILLIAMS%2C+MICHAEL+J&rft.inventor=MCLAUGHLIN%2C+MARK&rft.inventor=PENG%2C+FENG&rft.inventor=GIRIJAVALLABHAN%2C+VINAY+M&rft.inventor=MILCZEK%2C+ERIKA+M&rft.inventor=BELYK%2C+KEVIN+M&rft.date=2021-05-18&rft.externalDBID=C&rft.externalDocID=CA2998646C |